Berinert

Berinert is the first C1-esterase inhibitor to be licensed for the treatment of hereditary angioedema, a condition characterised by a deficiency of C1-esterase.

Berinert is suitable for use in adults, children and neonates.

View Berinert drug record

Further information: CSL Behring

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Added: ethinylestradiol and Sofradex.
Use our...

Melatonin 'should not be prescribed on NHS for jet lag'

Melatonin 'should not be prescribed on NHS for jet lag'

It is 'inappropriate' to make melatonin available on...

New MIMS section offers external resources to benefit your practice

New MIMS section offers external resources to benefit your practice

MIMS Hosted is a new section of the MIMS website providing...

Asthma and COPD Preparations and Compatible Devices

Asthma and COPD Preparations and Compatible Devices

Available presentations of bronchodilators and anti-inflammatories.